AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

RISPERIDONE 4 Mg ;

10 registrations across 1 African market— 10 active

Markets with RISPERIDONE 4 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
Apexidone 4 mg
Film Coated Tablets
🇪🇬EgyptApex pharmaactive
Zesperone 4 mg
Film Coated Tablets
🇪🇬EgyptSun pharma Egypt limitedactive
RISPERIDONE 4 mg
Film Coated Tablets
🇪🇬Egyptpharaonia pharmaceuticals (pharo pharma)active
Renoxydone
Film Coated Tablets
🇪🇬Egyptuniversal pharmaceutical industries (unipharma)active
Apexidone 4 mg
Film Coated Tablets
🇪🇬EgyptApex pharmaactive
Zesperone 4 mg
Film Coated Tablets
🇪🇬EgyptSun pharma Egypt limitedactive
RISPERIDONE 4 mg
Film Coated Tablets
🇪🇬Egyptpharaonia pharmaceuticals (pharo pharma)active
Itorisperidone 4 mg
Film Coated Tablets
🇪🇬EgyptInternational Trading Office ITOactive
Itorisperidone 4 mg
Film Coated Tablets
🇪🇬EgyptInternational Trading Office ITOactive
Renoxydone
Film Coated Tablets
🇪🇬Egyptuniversal pharmaceutical industries (unipharma)active

RISPERIDONE 4 Mg ; in Africa — Regulatory Overview

RISPERIDONE 4 Mg ; is registered across 1 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 10 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.